Viva Biotech's 15-Year Commitment to European Drug Discovery and Collaboration Celebrating 15 years of collaboration, Viva Biotech strengthens bonds with Europe's drug discovery community, fostering innovation and reliability in biopharmaceuticals.

Viva Biotech's 15-Year Commitment to European Drug Discovery and Collaboration #China #Shanghai #biopharmaceuticals #Drug_Discovery #Viva_Biotech

Viva Biotech Showcases Strong 2025 Results: AI Drug Discovery and CDMO Growth Uncovered Viva Biotech Reports impressive 2025 results showcasing growth in AI-driven drug discovery and rapid scaling of CDMO projects, reinforcing leadership.

Viva Biotech Showcases Strong 2025 Results: AI Drug Discovery and CDMO Growth Uncovered #China #Shanghai #Viva_Biotech #AI_Drug_Discovery #CDMO_Projects

Viva Biotech's 2025 Annual Report Highlights AI Advancements in Drug Discovery and CDMO Growth Viva Biotech recently announced impressive 2025 annual results highlighting significant advancements in AI-driven drug discovery and CDMO product scaling.

Viva Biotech's 2025 Annual Report Highlights AI Advancements in Drug Discovery and CDMO Growth #China #Shanghai #Drug_Discovery #CDMO #Viva_Biotech

Viva Biotech's Innovations in AI-Driven Drug Discovery with NVIDIA Technology Viva Biotech is leveraging NVIDIA technology to revolutionize drug discovery with AI, optimizing designs for improved outcomes in therapeutics and biological research.

Viva Biotech's Innovations in AI-Driven Drug Discovery with NVIDIA Technology #China #Shanghai #NVIDIA #Drug_Discovery #Viva_Biotech

Viva Biotech Partners with NVIDIA to Boost AI-Driven Drug Discovery Efforts Viva Biotech has teamed up with NVIDIA to enhance its innovative drug discovery process through AI. This collaboration aims to revolutionize the development of targeted therapeutics.

Viva Biotech Partners with NVIDIA to Boost AI-Driven Drug Discovery Efforts #China #Shanghai #NVIDIA #Drug_Discovery #Viva_Biotech

Exploring DMPK: How Viva Biotech Is Advancing Pharmacology Platforms in Drug Discovery Viva Biotech is innovating drug discovery with an integrated pharmacology platform that encompasses various modalities including small molecules and antibodies.

Exploring DMPK: How Viva Biotech Is Advancing Pharmacology Platforms in Drug Discovery #Shanghai #None #Pharmacokinetics #Viva_Biotech #DMPK

Exploring Pharmacology Innovations: Viva Biotech's Comprehensive DMPK Solutions Viva Biotech's groundbreaking DMPK pharmacology platform integrates diverse drug discovery modalities, facilitating efficient development from small molecules to antibodies.

Exploring Pharmacology Innovations: Viva Biotech's Comprehensive DMPK Solutions #China #Shanghai #Viva_Biotech #Pharmacology #DMPK

Viva Biotech's Arthrosi Enters $1.5 Billion Acquisition with Sobi Viva Biotech's Arthrosi Therapeutics has signed an acquisition agreement with Sobi worth up to $1.5 billion, enhancing gout treatment options.

Viva Biotech's Arthrosi Enters $1.5 Billion Acquisition with Sobi #Sweden #Stockholm #Sobi #Viva_Biotech #Arthrosi

Viva Biotech's Arthrosi Enters $1.5 Billion Acquisition Deal with Sobi Viva Biotech's incubated company, Arthrosi, has made headlines with its significant acquisition agreement with Sobi worth up to $1.5 billion.

Viva Biotech's Arthrosi Enters $1.5 Billion Acquisition Deal with Sobi #None #Sobi #Viva_Biotech #Arthrosi

Viva Biotech Earns Prestigious Frost & Sullivan Recognition for Innovation in Drug Discovery Technology Viva Biotech has received Frost & Sullivan's 2025 APAC Technology Innovation Leadership award, highlighting its cutting-edge AI-driven drug discovery methods.

Viva Biotech Earns Prestigious Frost & Sullivan Recognition for Innovation in Drug Discovery Technology #China #Shanghai #Frost_&_Sullivan #Drug_Discovery #Viva_Biotech

Viva Biotech Achieves Prestigious APAC Technology Innovation Award for Drug Discovery Viva Biotech has been recognized with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award for its groundbreaking AI-driven drug discovery methods, showcasing significant advancements in the pharmaceutical R&D field.

Viva Biotech Achieves Prestigious APAC Technology Innovation Award for Drug Discovery #China #Shanghai #Frost_&_Sullivan #Viva_Biotech #AI_Drug_Discovery

Viva Biotech Honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award Viva Biotech's groundbreaking AI-driven drug discovery platform has earned it the 2025 APAC Technology Innovation Leadership recognition from Frost & Sullivan.

Viva Biotech Honored with Frost & Sullivan's 2025 APAC Technology Innovation Leadership Award #None #Frost_&_Sullivan #Viva_Biotech #AI_Drug_Discovery

Exploring Cyclic Peptides: A New Era in Therapeutic Innovations by Viva Biotech Viva Biotech uncovers the therapeutic potential of cyclic peptides, bridging small molecules and biologics, focusing on oral drug discovery.

Exploring Cyclic Peptides: A New Era in Therapeutic Innovations by Viva Biotech #China #Shanghai #Drug_Discovery #Viva_Biotech #cyclic_peptides

Exploring the Future of Cyclic Peptide Therapeutics with Viva Biotech Viva Biotech sheds light on the potential of cyclic peptides for drug discovery, merging the benefits of small molecules and biologics.

Exploring the Future of Cyclic Peptide Therapeutics with Viva Biotech #None #Drug_Discovery #Viva_Biotech #cyclic_peptides

Viva Biotech's Strong Growth in 2025 Interim Results Shows Optimistic Trend for CRO and CDMO Ventures Viva Biotech has announced its 2025 interim results, showcasing significant growth in revenue and profit from its CRO and CDMO segments, indicating a positive trajectory for the company.

Viva Biotech's Strong Growth in 2025 Interim Results Shows Optimistic Trend for CRO and CDMO Ventures #China #Shanghai #CDMO #Viva_Biotech #CRO

Viva Biotech Reports Strong Growth in 2025 Interim Results: CRO Revenue and New CDMO Initiatives Viva Biotech's interim results reveal positive growth with CRO revenue and promising new CDMO projects, highlighting their advanced service offerings and innovative drug development strategy.

Viva Biotech Reports Strong Growth in 2025 Interim Results: CRO Revenue and New CDMO Initiatives #China #Shanghai #CDMO #Viva_Biotech #CRO

Viva Biotech Launches Revolutionary AI-Powered Drug Discovery Platform to Transform Pharmaceutical Development Viva Biotech has unveiled its innovative AI-Driven Drug Discovery platform, aiming to significantly enhance the speed and efficiency of drug research and development processes across the pharmaceutical industry.

Viva Biotech Launches Revolutionary AI-Powered Drug Discovery Platform to Transform Pharmaceutical Development #China #Shanghai #Drug_Discovery #Viva_Biotech #AIDD

Viva Biotech Unveils Revolutionary AI-Driven Platform for Innovative Drug Discovery Viva Biotech introduces its AI-Driven Drug Discovery platform, significantly enhancing pharmaceutical R&D efficiency and innovation. Discover more about this transformation.

Viva Biotech Unveils Revolutionary AI-Driven Platform for Innovative Drug Discovery #Hong_Kong #Viva_Biotech #AI-Driven_Drug_Discovery #AIDD_Platform

Viva Biotech's Langhua Pharmaceutical Achieves Fourth FDA cGMP Inspection Success Viva Biotech’s subsidiary, Langhua Pharmaceutical, has successfully passed a U.S. FDA cGMP inspection for the fourth time, reinforcing its global development capabilities.

Viva Biotech's Langhua Pharmaceutical Achieves Fourth FDA cGMP Inspection Success #China #Shanghai #FDA_Approval #Viva_Biotech #Langhua_Pharmaceutical

Viva Biotech Reports a Strong 2024: Embracing AI for the Future of Drug Development Viva Biotech Holdings announces impressive fiscal results for 2024, showing remarkable recovery driven by AI innovations in drug development and operational efficiency.

Viva Biotech Reports a Strong 2024: Embracing AI for the Future of Drug Development #None #Viva_Biotech #AI_Drug_Development #CRO_Growth

Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology Viva Biotech's portfolio companies, including TechnoDerma and VivaVision, have shared exciting updates, demonstrating significant progress in clinical trials and therapies aimed at various health conditions.

Viva Biotech's Portfolio Companies Showcase Promising Advances in Biotechnology #VivaVision #Viva_Biotech #Technoderma

Viva Biotech Launches New Branch in Boston, Marking Global Expansion Progress Viva Biotech has opened a new branch in Boston, USA, enhancing its drug development and manufacturing services. This strategic move boosts global market presence.

Viva Biotech Launches New Branch in Boston, Marking Global Expansion Progress #USA #Boston #Drug_Development #Viva_Biotech

Viva Biotech's Boston Branch: A Strategic Move in Global Expansion Viva Biotech's newly established Boston branch marks a key milestone in its global expansion strategy, enhancing collaboration in biopharma innovation.

Viva Biotech's Boston Branch: A Strategic Move in Global Expansion #USA #Cambridge #Viva_Biotech #Boston_Branch #Drug_Innovation